Specialized Intranasal Pain Relief Solutions

Publication ID: 24-11857520_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Intranasal Pain Relief Solutions,” Published Technical Disclosure No. 24-11857520_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857520_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,520.

Summary of the Inventive Concept

This inventive concept adapts the original therapeutic composition of intranasal lidocaine for specific, narrow markets or unique operational environments, providing targeted pain relief solutions for high-altitude environments, disaster relief, high-security needs, extreme weather conditions, and remote or isolated areas.

Background and Problem Solved

The original patent disclosed a preservative-free intranasal composition for treating various types of pain. However, this composition may not be suitable for specific, challenging environments or situations where standard pain relief solutions may not be effective or may pose risks. This inventive concept addresses these limitations by developing specialized variations of the original composition, tailored to meet the unique demands of these niche markets.

Detailed Description of the Inventive Concept

The new inventive concept comprises a series of specialized intranasal pain relief solutions, each designed to address the specific challenges of a particular environment or situation. For high-altitude environments, the composition is formulated to mitigate the effects of altitude-induced hypoxia on pain perception. In disaster relief scenarios, the system includes a portable, battery-powered nasal spray pump device and a cooling device to maintain the composition at a stable temperature. For high-security environments, the composition is formulated to minimize the risk of diversion or misuse. In extreme weather conditions, the portable, handheld nasal spray device features a waterproof and shock-resistant housing. Finally, for remote or isolated areas, the composition is designed to be stable at ambient temperatures and humidity levels.

Novelty and Inventive Step

The new inventive concept introduces novel and non-obvious variations of the original composition, specifically tailored to address the unique challenges of specialized markets and environments. These variations include the formulation of the composition to mitigate altitude-induced hypoxia, the integration of a cooling device in the disaster relief system, and the design of a waterproof and shock-resistant housing for the handheld device in extreme weather conditions.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the development of specialized nasal spray devices for use in other challenging environments, such as space exploration or underwater operations. Additionally, the composition could be adapted for use in veterinary medicine, providing targeted pain relief solutions for animals in various environments.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including pharmaceuticals, medical devices, disaster relief, and high-security services. The specialized pain relief solutions could be marketed to organizations operating in challenging environments, such as search and rescue teams, high-altitude research stations, or military units. The potential market for these solutions is substantial, with opportunities for partnerships, licensing agreements, and direct sales.

CPC Classifications

SectionClassGroup
A A61 A61K31/167
A A61 A61K9/0043
A A61 A61M11/00
A A61 A61M2210/0618

Original Patent Information

Patent NumberUS 11,857,520
TitleTherapeutic composition of intranasal lidocaine
Assignee(s)Nortic Holdings Inc.